Search In this Thesis
   Search In this Thesis  
العنوان
Full sequence analysis of F gene of NDV and comparative evaluation of genotype II and VII vaccines /
المؤلف
Selim, Karim Mohamed,
هيئة الاعداد
باحث / كريم محمد سليم سيد
مشرف / أحمد عبد الغنى السنوسي
مشرف / عبدالستار عرفه محمد
مشرف / عبد الله عبدالظاهر سليم
الموضوع
Newcastle disease virus.
تاريخ النشر
2018.
عدد الصفحات
194 P. :
اللغة
الإنجليزية
الدرجة
الدكتوراه
التخصص
البيطري
تاريخ الإجازة
1/1/2018
مكان الإجازة
جامعة القاهرة - كلية الطب البيطري - Virology
الفهرس
Only 14 pages are availabe for public view

from 244

from 244

Abstract

The present study was conducted using samples from seven suspected Newcastle disease virus (NDV) flocks of vaccinated chickens during 2012 to 2016 from 6 governorates in Egypt. The pathogenicity of the NDV isolates has been estimated through ICPI and ranged from 1.66 to 1.73 which indicates the velogenic type of NDV isolates. Pathotyping and genotyping of these isolates were done through sequencing of full length F gene. Results indicated that the seven NDV isolates showed characteristic cleavage site motif (112RRQKRF117) for the velogenic strains of NDV. Phylogenetic analysis of the F gene clustered these isolates within group I of genotype VIId within Israeli strains NDV/IS/2015, NDV-Ch/SD883, and most of Middle East strains. Six out of seven sequenced isolates have 6 potential N-linked glycosylation sites. The neutralization epitope on the 5 antigenic sites of fusion are conserved in all Egyptian strains of this study except NDV-KFR-B7-2012 which has a substitution at D170 G in epitope A4. In this study we compare two vaccination programs one using genotype VII inactivated and live NDV vaccine and second using genotype II inactivated and live vaccine. Contact chicks were added in both groups post challenge. The results indicated that both programs can protect birds from mortalities (up to 100 %). The vaccinated group with genotype VII was significantly prevent the virus shedding at 3th, 5th, 7th and 10th days post challenge unlike the genotype II vaccinated group.